Investing personality Jim Cramer recently called Recursion Pharmaceuticals a meme stock. The facts don't back up that position, though. Recursion may not be a meme stock, but that doesn't make it a ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

That brings us to Recursion Pharmaceuticals (RXRX 3.62%), a biotech company specializing in drug discovery using artificial intelligence (AI). At least one notable name in the investing world thinks ...